Calretinin, Mouse/Rat Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-Calretinin, Mouse/Rat antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Calretinin, Mouse/Rat |
| Clone | REA1157 |
| Host Species | Recombinant Human |
| Reactive Species | mouse, rat |
| Isotype | IgG1 |
| Format | phycoerythrin (PE) conjugate |
| Size | 200 µL |
| Concentration | 1:50 |
| Applications | MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Calretinin Antibody, anti-mouse/rat, PE, REAfinity™. Clone REA1157 recognizes the rat and mouse Calretinin, a neuron specific calcium binding protein, which is present in the central and peripheral nervous system, in retina and in many normal and pathological tissues. Caretininin coexists with Calbindin D-29 and parvalbumin in CNS and other peripheral tissues and is used as a marker for carcinomas and different tumors. | Additional information: Clone REA1157 displays negligible binding to Fc receptors. |
| Immunogen | n/a |
| Other Names | CR, Calb2, CAB29, calbindin 2 |
| Gene, Accession # | Gene ID: 12308, 117059 |
| Catalog # | 130-120-348 |
| Price | $222 |
| Order / More Info | Calretinin, Mouse/Rat Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Rogers, J. H. (1987) Calretinin: a gene for a novel calcium-binding protein expressed principally in neurons. J. Cell Biol. 105 (3): 1343-1353. | Gotzos, V. et al. (1996) The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type. Pathol Res Pract 192 (2): 137-147. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies